Related Experiment Videos

Nephroblastoma in infants, 1969-75: variations in treatment and survival

British Medical Journal
|November 8, 1980
PubMed

Insights

Nephroblastoma (kidney cancer) in infants under 1 year old showed high survival rates with nephrectomy and chemotherapy. Radiotherapy was not always necessary for early-stage tumors, with some cases cured by surgery alone.

Area of Science:

  • Pediatric Oncology
  • Nephrology

Background:

  • Nephroblastoma, a common kidney cancer in infants, requires effective treatment strategies.
  • Understanding treatment outcomes is crucial for improving survival rates in young patients.

Purpose of the Study:

  • To evaluate the survival rates and treatment efficacy for infants diagnosed with nephroblastoma.
  • To determine the impact of different treatment modalities (nephrectomy, radiotherapy, chemotherapy) on outcomes.

Main Methods:

  • Retrospective analysis of 79 infants under 1 year old diagnosed with nephroblastoma between 1969-1975.
  • All patients underwent nephrectomy; treatment groups included those receiving radiotherapy and/or chemotherapy.

Main Results:

  • Overall three-year survival rate was 65% for patients surviving at least one week post-diagnosis.
  • Stage I tumors had a 76% survival rate.
  • Survival was significantly higher for early-stage tumors treated with nephrectomy and chemotherapy alone compared to those including radiotherapy.

Conclusions:

  • Nephrectomy combined with chemotherapy can be sufficient treatment for many infants with nephroblastoma.
  • In some cases, nephrectomy alone may be adequate for cure.
  • Infants under one year old generally tolerate chemotherapy well.

Related Concept Videos